| Intervention category | Mean Percent* (95% CI) | Forecast Percent† (95% CI) |
|---|---|---|
| First Subgraph | ||
| Pharmacological | ||
| Anticholinergic (C) | 16.7 (7.7, 32.5) | 16.7 (4.1, 48.6) |
| Nonpharmacological | ||
| Neuromodulation + Behavioral Therapy (N+T) | 69.5 (34.5, 90.8) | 69.5 (24.6, 94.1) |
| Behavioral Therapy (T) | 35.6 (25.2, 47.7) | 35.6 (12.3, 68.6) |
| Combination | ||
| Hormones + Behavioral Therapy (H+T) | 70.1 (35.1, 91.0) | 70.1 (25.1, 94.3) |
| Hormones + Neuromodulation + Behavioral Therapy (H+N+T) | 25.6 (7.2, 60.3) | 25.6 (4.6, 71.0) |
| No treatment | ||
| Placebo/Sham/No Treatment (P) | 12.7 (7.1, 21.8) | 12.7 (3.4, 38.0) |
| Second Subgraph | ||
| Pharmacological | ||
| Hormones (H) | 1.7 (0.1, 21.7) | 1.7 (0.1, 21.7) |
| Anticholinergic + Hormones (C+H) | 1.7 (0.1, 21.7) | 1.7 (0.1, 21.7) |
The summary mean percentage (with confidence interval) of women in the trials receiving the intervention with the outcome.
The predicted percentage (with confidence interval) of women who receive the intervention in future trials, or in similar settings, who will have the outcome.
From: Appendix H, Results of Subgroup Analyses by Type of UI
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.